Alpha-methyltryptamine and 5-(2-methylaminopropyl)-benzofuran (5-MAPB) fatal co-intoxication: case report and review of literature.
Marie EpainNathalie CartiserFabien BevalotCharline BottinelliCamille ChatenayLaurent FantonPublished in: International journal of legal medicine (2024)
The scientific literature contains little reliable data regarding new psychoactive substances and designer drugs, making it difficult to assess toxic blood levels and potentially lethal threshold. Here, we report a fatal co-intoxication involving two uncommon drugs ‒ alpha-methyltryptamine (AMT) and 5-(2-methylaminopropyl)-benzofuran (5-MAPB) ‒ combined with exposure to benzodiazepines, ephedrine, and norephedrine. AMT and 5-MAPB were quantified using ultra-high performance liquid chromatography coupled to tandem mass spectrometry (UHPLC/MS-MS), revealing concentrations of AMT 4690 ng/mL and 5-MAPB 101 ng/mL in postmortem peripheral blood. We additionally reviewed the literature to help interpret the likely roles of these molecules in the occurrence of death.
Keyphrases
- ultra high performance liquid chromatography
- tandem mass spectrometry
- ms ms
- high performance liquid chromatography
- simultaneous determination
- peripheral blood
- liquid chromatography
- high resolution mass spectrometry
- gas chromatography
- systematic review
- solid phase extraction
- liquid chromatography tandem mass spectrometry
- high resolution
- risk assessment
- mass spectrometry
- electronic health record
- big data
- machine learning
- drug induced